Camp Lejeune Victims Can Now Sue For Contaminated Water Exposure

Congress recently passed the Camp Lejeune Justice Act of 2022, which will allow people who were harmed by contaminated water at the historic military base to sue for compensation. Up until now, people who lived at Camp Lejeune suffered from serious illnesses, including life-altering disabilities, without an opportunity to obtain justice. With the passage of this law, victims will now be able to bring lawsuits against the government for all the harm they suffered.

(more…)

3 Product Liability Claims for a Successful Case in Pennsylvania

Strict Product Liability, Negligence, and Breach of Warranty Explained

Over the past thirty (30) years, I have observed Pennsylvania Products Liability Law change; but, its fundamentals remain the same – Pennsylvania Strict Products Liability is intended to deter the sale of defective products by preventing product designers from “using consumers as guinea pigs”.

People who are injured by defective products can hold product sellers strictly liable for their injuries and damages by proving that the product is defectively designed, that it was defective because it did not have adequate instructions or warnings, or if the product is sold with a manufacturing defect.

Arthur Bugay

Partner, Williams Cedar, LLC

Tincher v. Omega-Flex, Inc., 104 A.3d 328, 404 (Pa. 2014). Pennsylvania is still the best state for a product liability claim. In Tincher, supra, the Pennsylvania Supreme Court held that Pennsylvania will continue to follow §402A of the Restatement (Second) of Torts, which applies Strict Liability to product sellers for selling a defective product that has harmed its user or consumer. In Pennsylvania, even where “the seller has exercised all possible care in the preparation and sale of his [or her] product, and . . . the user or consumer has not bought the product from or entered into any [sales contract] with the seller[,]” a seller that is “engaged in the business of selling such . . . product[s]. . . is subject to liability for physical harm thereby caused to the ultimate user or consumer, or to his [or her] property. . . .”

People who are injured by defective products can hold product sellers strictly liable for their
injuries and damages by proving that the product is defectively designed, that it was defective
because it did not have adequate instructions or warnings, or if the product is sold with a
manufacturing defect. Moreover, a design defect can be proven by showing that the product
failed to perform as well as an average consumer or user of the product would have expected the
product to perform. Another way to prove a design defect is through circumstantial evidence of
defect, such as through a product malfunction.

What are Examples of Product Liability Cases?

Here are a few cases that I have litigated for client recovery that provide some insight into successful strict product liability claims:

  • The man whose vape pen ignited his pants while he was attending a music event;
  • Workers whose personal protective equipment (PPE), such as clothing, does not protect
    them from a work hazard because the PPE did not have a safe design or construction for
    the work to be performed;
  • Examples of such PPE are (1) PPE coveralls that ignited when worn during work by a
    shipfitter, who was “washing a weld” with a welding torch; (2) the welder who suffered
    burns after his PPE “flame resistant” shirt ignited; (3) the furnace worker who suffered
    full thickness burns to his foot and bone when his “molders’ boot” ignited when
    contacted by a liquified aluminum compound.
  • A man who was injured when his bicycle’s metal pedal crank broke while he was using
    his bike;
  • The worker who was crushed by a metal door when a chain hoist’s metal hook broke.

What are Examples of a Defective Product?

There are many other examples. Sometimes, the defect occurs because the materials are defective such as, for example, with metal failures, such as for the two examples above. This can be from both a design and a manufacturing defect caused, for example, where the metal is not forged properly and fails to sufficiently anneal to the proper hardness for its designed purpose. Other times, a product may be defective because a product’s components are not designed for the seller’s intended purpose for the product.

For example, in the “molders’ boot” example, the boot was referred to as a “kick off” because it had elasticized side panels that the seller intended for safety, to enable a worker to quickly kick off the boot if hot molten metal came into contact with it, during use. However, the manufacturer of the product used an elasticized side panel design that it took from the design of a “ladies dress boot”. It was made of cotton and quickly ignited and offered no protection to the molder, thereby defeating its advertised purpose.

What is Product Misrepresentation?

Such occurrences provide another separate liability claim, strict liability for the “misrepresentation by [a] seller” of the material uses and applications for a product pursuant to §402B of the Restatement (Second) of Torts, which is adopted in Pennsylvania. These matters also provide a claim for the injured person under the Pennsylvania Commercial Code, for a breach of an express warranty.

For that matter, whenever a product is not “fit for its particular purpose” or is defective — by design, manufacture, from malfunction, or because it is sold without proper warnings or instructions — the product seller may be held strictly liable because of the seller’s breach of an implied warranty for the subject product.

What are Examples of a Defective Design?

In short, whenever there is a design which could feasibly have made the product safer for use by eliminating or minimizing the product’s hazards, a manufacturer, seller, and all within the chain of the product’s distribution, may be held strictly liable for the products “unreasonably dangerous” condition without regard to whether the manufacturer or seller had exercised “all possible care” in their respective preparation and sale of the product. A simple way to evaluate such defects is through the “hindsight test”. If, after the product was sold, where it injures its user or consumer, the product manufacturer and seller should be held strictly liable where there is an alternative design that would have prevented the injury that, in hindsight, should have been used or implemented.

See, e.g., Bugay, “A New Era In Pennsylvania Products Liability Law- Tincher v. Omega-Flex, Inc.: The Death of Azzarello,” The Pennsylvania Bar Association Quarterly (Jan. 2015).

For example, another matter I litigated many years ago, a young girl who worked in a supermarket’s deli department was injured while cleaning the area underneath the deli slicer. The slicer’s design included a lifting lever that would prop the slicer up so the worker could clean underneath it, required after each shift to satisfy health code requirements. The slicer’s lever design was premised upon positional stability and did not include a locking system to hold the slicer’s lever in the upright position to prevent the lever’s accidental disengagement such as, from the worker’s bumping against the slicer’s lift lever during the cleaning process, while the slicer was in its upright position.

However, another slicer manufacturer had designed a lifting lever with a positive locking safety component which required the worker to affirmatively release the lever for the lever to be lowered and prevented its accidental disengagement during the cleaning process. The alternative design was called the “Sure lock lift” and was patented.

During litigation, the manufacturer argued that (1) it did not know about the design; (2) that its industry standard did not required the alternative design; (3) that the patented design did not exist when the product was sold; and (4) that the competitor’s lever design was patented and could not be implemented by the manufacturer anyway. Pennsylvania strict liability law prevents these defenses from being applicable or even relevant for consideration at trial. All claimed evidence of such defenses would have been excluded if that matter had not resolved before trial.

Simply stated, the safety design is well known, based on a ratchet and pawl application, such as, for example, used for a socket wrench, which restricts movement in a certain direction. Moreover, this safety technology was well known and available. Leonardo DaVinci had drawings of ratchet and pawl designs. It did not matter that the manufacturer did not know about the feasible design, this is not a defense. It did not matter that the manufacturer had followed industry standards or what it claimed to be the “state of the art” for its product, Pennsylvania products liability law does not care — the manufacturer and seller can be held to be strictly liable anyway. It did not
matter that the product was sold before the “Sure Lock Lift” was patented; nor did it matter that a competitor had patented the design and that its use was restricted.

As the United States Court of Appeals for the Third Circuit, applying Pennsylvania strict liability law, held regarding a different product, where a similar argument was made by the manufacturer, “Pennsylvania’s public policy is such that manufacturers of products are encouraged to make them as safe as possible, as soon as possible.” Habecker v. Clark Equipment Co., 36 F.3d 278, 286 (3d Cir.
1994).

When Can Product Liability Cases Include Negligence Lawsuits?

People injured by “unreasonably dangerous” or defective products may also bring negligence lawsuits against product sellers. These are negligence cases where a manufacturer or seller is held liable where they have not exercised reasonable care with regard to the design, manufacture, or sale of their products. Product negligence claims can be and are usually brought by injured people, through counsel, in the same lawsuit as their strict liability and breach of warranty claims.

Over the years, I have represented many people who have been injured by defective and dangerous products, in Pennsylvania, in New Jersey, and in other states, including in California. These have involved a great variety of products, from log splitters to potato chip conveyors. Among the product claims are pneumatic nailers, table saws, conveyor systems, bicycles, and industrial and consumer products.

If you are injured by a product, please contact me. I would like to help you obtain a recovery for your injuries.

 

About the Author

Arthur Bugay is a Partner in the law firm of Williams Cedar LLC. After obtaining his Bachelor’s and Master’s Degrees in Economics from Temple University, he attended Temple Law School, graduating with honors. Arthur also has two Master of Law degrees from Temple University, one in Taxation and the other in Trial Advocacy. Arthur’s practice areas include Products Liability, Construction Accident litigation, Personal Injury litigation, Negligent Security and Employment law.

Eminent Trial Lawyer, Arthur Bugay, Joins Williams Cedar as Partner

Trial Lawyer and Litigator Adds Experience to Firm’s Focus on Civil Rights and Environmental Law

PHILADELPHIA, October 11 (Williams Cedar Law Firm) – Williams Cedar, LLC is proud to announce that trial lawyer Arthur L. Bugay has joined the firm as a partner and products liability and catastrophic injury attorney, working in its Philadelphia office. Prior to joining Williams Cedar, Arthur was a partner at Galfand Berger.

“I’ve known Art for many years, and have worked with him as co-counsel on multiple complex cases in which he’s proved himself to be a strong and thorough advocate for our clients,” said Williams Cedar co-founder Gerald Williams. “I’m very happy that I will now have the chance to work with him as my partner.”

Mr. Bugay has had a distinguished career of more than 30 years during which he has established himself as an eminent trial lawyer. He has successfully represented plaintiffs in a wide range of complex litigation, including workplace accidents, trucking and other motor vehicle claims and product liability claims. Licensed both in New Jersey and Pennsylvania, Arthur’s work has resulted in multiple $1 million+ outcomes on behalf of plaintiffs.  With Williams Cedar, Mr. Bugay will be adding his experience and talent to the firm’s complex litigation teams for environmental, civil rights and personal injury cases.

Having worked with Jerry Williams on other cases over the past twenty years, I am very happy to be joining Williams Cedar because this firm complements my specialties in complex civil litigation and protecting Workers in the Workplace. I am also looking forward to adding my skills to the firm’s Environmental Law cases, where it represents clients from around the country for groundwater and toxic chemical contamination.

Arthur Bugay

Partner, Williams Cedar, LLC

Mr. Bugay is an AV Rated Attorney and has been a Pennsylvania Super Lawyer every year since 2010.  He is a member of the Multi-Million Dollar Advocates and received the 2012 George Douglas Award for Appellate Advocacy by the Pennsylvania Association of Justice.

“Arthur is a rare talent and we’re thrilled to have him on the Williams Cedar team,” added co-founding partner David Cedar.  “His skill set blends perfectly with our legal team approach to complex litigation.”

In addition to his practicing legal career, Arthur taught products liability law at Temple University Beasley School of Law. He also taught economics and business law at Temple University, Moravian College and Montgomery County Community College.

Mr. Bugay is a proud Temple University graduate who is among only four people, among more than 317,000 graduates, who have received five degrees from Temple University — Bachelor of Arts (Economics); Master of Arts (Economics); Law; Master of Laws (Taxation); and Master of Laws (Trial Advocacy).

Join us in welcoming Art to the WC family. We look forward to a long and successful relationship together.

About Williams Cedar

Williams Cedar has a proven track record of protecting the personal, civil, and consumer rights of clients throughout the country, and New Jersey and Pennsylvania in particular. From personal injury cases and civil rights cases to individual and class action environmental toxic tort cases, our diverse and experienced legal team has an extensive understanding of the law and what it takes to secure maximum cash settlements for our clients.

Federal Court Boots Medtronic Insulin Pump Recall Litigation to State Court

Kevin Haverty, Defective Medical Device Lawyer

Concluding that the court lacked jurisdiction, United States District Court judge Dolly M. Gee remanded a case involving the recent Medtronic insulin pump recall of its 600 series insulin infusion pumps to the California state court where it originated. The case, Plum, et al. v. Medtronic, was originally filed in California Superior Court in Los Angeles on behalf of 7 plaintiffs – all Type I diabetics – who allegedly suffered injuries relating to defective retainer rings on the insulin reservoir chamber which caused either over- or under-infusion of insulin. In February 2020 the FDA ordered a recall of more than 300,000 Medtronic 630G and 670G model pumps due to “broken or missing” retainer rings. It was reported that Medtronic had received over 26,000 complaints which included 2,175 reports of injuries and 1 death.

Medtronic had removed the case to federal court claiming both diversity and federal question jurisdiction and then moved to sever the plaintiffs claiming that one – a resident of California – was fraudulently misjoined to destroy diversity jurisdiction. The company also argued that the court had jurisdiction because plaintiffs’ claims are preempted under federal law thereby implicating federal question jurisdiction. The court rejected both contentions.

While noting that the issue of misjoinder in a state case is more properly addressed to the state court, the court nevertheless addressed Medtronic’s argument that the joinder of the plaintiffs in Plum was so “egregious” as to amount to fraud saying:

Plaintiffs bought nearly identical types of insulin pumps from the same manufacturer and suffered the same type of injury as a result of the same alleged defect. These commonalities support the conclusion that Plaintiffs’ claims “arose out of the same series of transactions or occurrences” – namely a manufacturing defect – thus satisfying the first prong of joinder analysis under Federal Rule of Civil Procedure 20. In addition, because there need only be “some questions of fact and law common to all of the plaintiffs” to satisfy the second prong of the joinder analysis, this prong is also satisfied by Plaintiffs’ allegations. Thus, Plaintiffs’ claims cannot be severed on this basis even if the Ninth Circuit adopted the theory of fraudulent misjoinder. The California citizenship of both Weisshar and Minimed precludes this Court from exercising jurisdiction based on party diversity.

The claim of federal question jurisdiction based upon the affirmative defense of preemption was easily dispatched by the court who observed that “in the Ninth Circuit, it is “settled law” that Plaintiffs’ anticipation of a preemption defense does not create federal question jurisdiction.”

In the absence of subject matter jurisdiction, the court remanded the case to the Superior Court.

WILLIAMS CEDAR Partner KEVIN HAVERTY, along with JULIA REED ZAIC and LAURA SMITH HATCH of HEAVISIDE REED ZAIC in Newport Beach, CA represent the plaintiffs.

Julia Reed Zaic, Lawyer
Laura Smith Hatch, Lawyer

U.S. Supreme Court Rejects Appeal of 9th Circuit Decision Allowing Expert Testimony in Products Case Involving Rare Cancer

In a decision with important implications for the admission of expert testimony in cases involving rare diseases, the Supreme Court of the United States declined to review a decision of the 9th Circuit which reversed a trial court’s decision barring plaintiff’s experts from testifying about the cause of plaintiff’s cancer.  Wendell v. GlaxoSmithKline, 838 F. 3d 1227 (9th Cir. 2017), cert. den. ___ S.Ct. ___ (2018).

In 2007, at the age of 21 and after years of taking a combination of drugs to treat his ulcerative colitis, Maxx Wendell developed a rare and deadly form of lymphoma called hepatosplenic T-cell lymphoma. In the years leading up to his diagnosis these drugs had increasingly been associated with this form of lymphoma particularly in young males with ulcerative colitis, although it’s exceeding rarity made it nearly impossible to specifically quantify the risk through epidemiologic studies.  While the background risk for this cancer (which had only first been identified in 1994 with only 200 or so cases reported in the medical literature worldwide from the 1990’s until the mid-2000’s) was understood to be approximately 1 in six million, the risk in young males with ulcerative colitis taking this combination of drugs increased to 1 in 35,000; a 300-fold increase in risk among this particular group.

Maxx’s parents, Lisa and Stephen Wendell brought an action against the manufacturers of the drugs used to treat his ulcerative colitis and produced two experts who were among the world’s leading experts on T-cell lymphomas.  Both of the experts testified that the absolute rarity of the disease generally, combined with the highly specific incidence in young male patients with ulcerative colitis taking a particular combination of drugs, made it more likely than not that Maxx’s HSTCL was caused by the use of these medications; particularly in the absence of any other risk  factors.  Both experts testified that they relied upon differential diagnosis in reaching this conclusion even in the face of no epidemiologic studies which they explained would be impossible to conduct given the rarity of the disease.

The district court excluded the opinions of these experts under Daubert v. Merrill Dow, finding their opinions unreliable because not based on epidemiologic studies and because their opinions were formed for litigation purposes and not for publication in the medical literature.  On appeal, the 9th Circuit reversed holding that the district court “looked too narrowly at each individual consideration, without taking into account the broader picture of the experts’ overall methodology . . . [and] improperly ignored the experts’ experience, reliance on a variety of literature and studies, and review of Maxx’s medical records and history, as well as the fundamental importance of differential diagnosis by experienced doctors treating troubled patients.”   The appeals court took particular aim at the over-reliance on the existence or absence of epidemiological studies as a criteria for evaluating the reliability of an expert’s methodology for Daubert purposes noting its fundamental unavailability in the cases of rare dieases:

Perhaps in some cases there will be a plethora of peer reviewed evidence that specifically shows causation. However, such literature is not required in each and every case. “The first several victims of a new toxic tort should not be barred from having their day in court simply because the medical literature, which will eventually show the connection between the victims’ condition and the toxic substance, has not yet been completed.

Thus, court concluded “[i]n the case of a rare disease like HSTCL, the Supreme Court’s mandate that in determining the admissibility of expert testimony, the focus ‘must be solely on principles and methodology, not on the conclusions that they generate’ is especially important.”  And, “[w]here, as here, the experts’ opinions are not the ‘junk science’ Rule 702 was meant to exclude, the interests of justice favor leaving difficult issues in the hands of the jury and relying on the safeguards of the adversary system—’vigorous cross-examination, presentation of contrary evidence, and careful instruction on the burden of proof’—to ‘attack shaky but admissible evidence.’”

The case has significant implications for the admission of expert testimony in cases involving rare diseases for which no epidemiologic evidence either doesn’t exist or may never exist because of the disease’s rarity.  The broader import of the decision is a rejection of what has become an almost mechanical binary gatekeeping application of Daubert heavily reliant on the presence or absence of epidemiology.  The decision recognizes that reliable opinions can be based upon multiple factors and district courts must (at least in the 9th Circuit) be sensitive to the context in which the expert opinions are formulated.

Williams Cedar partner Kevin Haverty was trial and appellate counsel for the Wendells, and, together with Michael Quirk of the Berezofsky Law Group, represented the family on appeal.

For more information, call our legal team at 215-557-0099 or contact us online.